Преглед аутора: "Gul, Sheraz"
Приказ резултата 1-12 од 12
-
Computer-Aided Drug Design and Evaluation of Selective HDAC Inhibitors
Ružić, Dušan; Đoković, Nemanja; Petković, Miloš; Agbaba, Danica; Gul, Sheraz; Lahtela-Kakkonen, Maija; Ganesan, A.; Nikolić, Katarina (EuChemS (European Chemical Society), 2019) -
Computer-aided drug design and evaluation of selective inhibitors against cytoplasmic histone deacetylases
Ružić, Dušan; Đoković, Nemanja; Petković, Miloš; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Nikolić, Katarina (American Chemical Society Division of Medicinal Chemistry, 2022) -
Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation
Ružić, Dušan; Ellinger, Bernhard; Đoković, Nemanja; Santibanez, Juan; Gul, Sheraz; Beljkaš, Milan; Đurić, Ana; Ganesan, Arasu; Pavić, Aleksandar; Srdić-Rajić, Tatjana; Petković, Miloš; Nikolić, Katarina (MDPI, 2022) -
Dual LSD1 and HDAC6 Inhibition Induces Doxorubicin Sensitivity in Acute Myeloid Leukemia Cells
Bulut, Ipek; Lee, Adam; Cevatemre, Buse; Ružić, Dušan; Belle, Roman; Kawamura, Akane; Gul, Sheraz; Nikolić, Katarina; Ganesan, A.; Acilan, Ceyda (MDPI, 2022) -
Epigenetic drug discovery: Successful examples of Computer-Aided Drug Designing of Histone Deacetylase (HDAC6 and SIRT2) and Histone Methyltransferase (DOT1L) inhibitors
Ružić, Dušan; Đoković, Nemanja; Corentin, Bon; Petković, Miloš; Ellinger, Bertrand; Gul, Sheraz; Santibanez, Juan; Lahtela-Kakkonen, Maija; Halby, Ludovic; Ganesan, A.; Srdić Rajić, Tatjana; Arimondo, Paola; Nikolić, Katarina (e-EuCo-CTC 2021, Online conference, EuChemS Division of Computational and Theoretical Chemistry, November 18-19 2021, 2021) -
Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies? / Постоји ли граница између цитотоксичног и антиметастатског ефекта селективних инхибитора хистон деацетилазе 6 код солидних тумора?
Nikolić, Katarina; Ružić, Dušan; Beljkaš, Milan; Petković, Miloš; Gul, Sheraz; Santibanez, Juan; Srdić Rajić, Tatjana (Serbian Medical Society Oncology Section, 2019) -
Multitargeting epi-epi drugs for multidrug reistance
Lee, Adam; Ganesan, A.; Bulut, İpek; Açılan Ayhan, Ceyda; Ružić, Dušan; Nikolić, Katarina; Gul, Sheraz (COST Action 17104 (STRATAGEM), 2020) -
Novel 1-benzhydryl piperazine derivative inhibits the migration and invasiveness of breast cancer cells: Synthesis, molecular modelling and biological characterization
Ružić, Dušan; Petković, Miloš; Gul, Sheraz; Santibanez, Juan; Srdić-Rajić, Tatjana; Nikolić, Katarina (European Association for Cancer Research, 2021) -
Rational design and evaluation of selective HDAC inhibitors
Ružić, Dušan; Đoković, Nemanja; Petković, Miloš; Agbaba, Danica; Gul, Sheraz; Lahtela-Kakkonen, Maija; Ganesan, A.; Nikolić, Katarina (European Cooperation in Science and Technology (COST), 2019) -
Rational design and in vitro evaluation of selective inhibitors of cytoplasmic histone deacetylases SIRT2 and HDAC6
Ružić, Dušan; Đoković, Nemanja; Petković, Miloš; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Srdić-Rajić, Tatjana; Nikolić, Katarina (European Federation for Medicinal Chemistry and Chemical Biology (EFMC), Société de Chimie Thérapeutique (SCT), 2022) -
Rational design, synthesis and in vitro testing of selective HDAC6 and SIRT2 inhibitors
Ružić, Dušan; Đoković, Nemanja; Petković, Miloš; Agbaba, Danica; Gul, Sheraz; Lahtela‐Kakkonen, Maija; Ganesan, A.; Santibanez, Juan; Srdić-Rajić, Tatjana; Nikolić, Katarina (EFMC-ISMC, 2021) -
Synthesis, molecular modelling and biological characterization of novel antimigratory and antiinvasive 1-benzhydryl piperazine derivatives
Ružić, Dušan; Petković, Miloš; Ellinger, Bernhard; Gul, Sheraz; Santibanez, Juan; Srdić-Rajić, Tatjana; Nikolić, Katarina (EFMC-ISMC, 2021)